Figure 1From: Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells Parallel screening of drugs from the Johns Hopkins Chemical Compound Library as TRAIL sensitizers. PC3-TR human prostate cancer cells were first incubated with drug treatments (10 μM) for 24 hours after which time the media was removed, refreshed and cells were treated with TRAIL (10 ng/mL) for an additional 24 hrs.Back to article page